Celcuity LLC (CELC)

Currency in USD
124.64
+7.70(+6.58%)
Closed·
124.65+0.01(+0.01%)
·
Trading near 52-week High
CELC is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
115.68124.64
52 wk Range
8.54124.64
Key Statistics
Prev. Close
116.94
Open
116.8
Day's Range
115.68-124.64
52 wk Range
8.54-124.64
Volume
1.12M
Average Volume (3m)
728.78K
1-Year Change
1,340.9249%
Book Value / Share
2.17
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CELC Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
128.60
Upside
+3.18%
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Celcuity LLC News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Celcuity Inc., a clinical-stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States. The company’s lead drug candidate includes Gedatolisib, which selectively targets various Class I isoforms of phosphatidylinositol-3-kinase (PI3K) and the two mechanistic targets of rapamycin (mTOR) sub-complexes, mTORC1 and mTORC2 to treat patients with hormone receptor positive (HR+), human epidermal growth factor receptor 2 negative (HER2-) or HR+/HER2-, advanced or metastatic breast cancer (ABC), and patients with metastatic castration resistant prostate cancer (mCRPC). The company had a license agreement with Pfizer Inc. for the development and commercialization rights to Gedatolisib. Celcuity Inc. was incorporated in 2011 and is based in Minneapolis, Minnesota.

Celcuity LLC Earnings Call Summary for Q4/2025

  • Celcuity reported Q4 2025 EPS of -$0.73, beating forecast of -$1.05 by 30.48%; stock rose 2.93% to $105 in aftermarket trading.
  • Net loss increased to $51M ($0.97/share) from $36.7M ($0.85/share) in Q4 2024, driven by higher R&D and commercialization expenses.
  • Company maintains strong cash position of $441.5M, providing sufficient runway to fund operations through 2027.
  • Strategic focus on commercialization infrastructure and product launch preparation continues despite elevated operating expenses.
  • No specific revenue guidance provided; executives project continued EPS losses as company invests in growth initiatives and product development.
Last Updated: 25/03/2026, 22:34
Read Full Transcript

Compare CELC to Peers and Sector

Metrics to compare
CELC
Peers
Sector
Relationship
P/E Ratio
−34.0x−2.5x−0.4x
PEG Ratio
0.95−0.020.00
Price/Book
59.8x5.0x2.6x
Price / LTM Sales
-7.5x3.2x
Upside (Analyst Target)
7.3%344.3%50.6%
Fair Value Upside
Unlock9.4%6.6%Unlock

Analyst Ratings

10 Buy
1 Hold
0 Sell
Ratings:
11 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 128.60
(+3.18% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
H.C. Wainwright
Hold94.00-24.58%-MaintainMar 27, 2026
Craig-Hallum
Buy141.00+13.13%108.00MaintainMar 26, 2026
Stifel
Buy125.00+0.29%115.00MaintainMar 26, 2026
Jefferies
Buy138.00+10.72%134.00MaintainMar 26, 2026
Wolfe Research
Buy110.00-11.75%-MaintainMar 12, 2026

Earnings

Latest Release
Mar 25, 2026
EPS / Forecast
-0.73 / -1.05
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

CELC Income Statement

People Also Watch

284.17
COHR
+0.84%
16.150
AMPX
-4.55%
96.22
RVMD
-0.55%
177.70
AVAV
-4.94%
320.24
PRAX
+0.01%

FAQ

What Is the Celcuity (CELC) Stock Price Today?

The Celcuity stock price today is 124.64 USD.

What Stock Exchange Does Celcuity Trade On?

Celcuity is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Celcuity?

The stock symbol for Celcuity is "CELC."

What Is the Celcuity (CELC) Afterhours Price Today? (Afterhours variable test: 124.65) Current Date: Apr 10, 2026

After hours price: 124.65. After hours price change (units): 0.01. Price change percentage: 0.01%

What Is the Celcuity Market Cap?

As of today, Celcuity market cap is 6.02B USD.

What Is Celcuity's Earnings Per Share (TTM)?

The Celcuity EPS (TTM) is -3.79.

When Is the Next Celcuity Earnings Date?

Celcuity will release its next earnings report on May 18, 2026.

From a Technical Analysis Perspective, Is CELC a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Celcuity Stock Split?

Celcuity has split 0 times.

How Many Employees Does Celcuity Have?

Celcuity has 155 employees.

What is the current trading status of Celcuity (CELC)?

As of Apr 10, 2026, Celcuity (CELC) is trading at a price of 124.64 USD, with a previous close of 116.94 USD. The stock has fluctuated within a day range of 115.68 USD to 124.64 USD, while its 52-week range spans from 8.54 USD to 124.64 USD.

What Is Celcuity (CELC) Price Target According to Analysts?

The average 12-month price target for Celcuity is 128.60 USD, with a high estimate of 155 USD and a low estimate of 94 USD. 10 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +3.18% Upside potential.

What Is the CELC Premarket Price?

CELC's last pre-market stock price is 116.80 USD. The pre-market share volume is 2,460.00, and the stock has decreased by -0.14, or -0.12%.

What Is the CELC After Hours Price?

CELC's last after hours stock price is 124.65 USD, the stock has decreased by 0.01, or 0.01%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.